Bain Capital Life Sciences Investors, LLC Pharvaris N.V. Transaction History
Bain Capital Life Sciences Investors, LLC
- $662 Million
- Q1 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 3,303,381 shares of PHVS stock, worth $56.2 Million. This represents 11.53% of its overall portfolio holdings.
Number of Shares
3,303,381
Previous 3,904,319
15.39%
Holding current value
$56.2 Million
Previous $110 Million
30.29%
% of portfolio
11.53%
Previous 13.84%
Shares
4 transactions
Others Institutions Holding PHVS
# of Institutions
35Shares Held
37.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$128 Million4.07% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$72.9 Million38.74% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.04MShares$68.7 Million47.16% of portfolio
-
Viking Global Investors LP3.65MShares$62.1 Million0.32% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$57.7 Million6.74% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $574M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...